Integrated expertise across science, regulation, and strategy.

Evidence-based regulatory advice including FDA strategy, agency meeting support, submission strategy, labeling review, and compliance planning.

Regulatory interpretation, agency engagement, policy analysis, submission strategy, enforcement risk, compliance planning, and science-based positioning across regulated product categories.

Rigorous evaluation encompassing literature reviews, toxicological assessments, clinical evidence evaluation, and claims substantiation.

Evaluation of clinical, toxicological, analytical, and published evidence to support product development, substantiation, safety, risk assessment, and defensible scientific conclusions.

Independent advice for leadership on matters with material enterprise implications, including due diligence and strategic risk assessment.

Independent advice for executive leadership, boards, investors, and legal teams confronting decisions with material scientific, regulatory, governance, or commercial implications.

Practical strategies for quality systems, GMP support, gap assessments, corrective/preventive actions, and organizational training.

Quality systems, cGMP, documentation, corrective action, professional standards, regulatory readiness, and the development of durable organizational capability.

Integrated strategy for translating innovation into safe, compliant products, including botanical development and commercialization analysis.

Product development, regulatory pathways, botanical and biotechnology innovation, scientific claims, market readiness, and the responsible translation of evidence into commercial value.

Frameworks strengthening professional judgment, institutional knowledge, and organizational learning systems.

Development of professional standards, decision frameworks, legally defensible reasoning, transparent communication, organizational learning, and stewardship of institutional knowledge.